These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5484024)

  • 21. Histochemical and ultrastructural examinations in the Stein-Leventhal syndrome.
    Tóth F; Horn B; Csömör S
    Acta Morphol Acad Sci Hung; 1970; 18(3):293-306. PubMed ID: 4253320
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathophysiology of the polycystic ovary syndrome].
    Alieva EA; Pshenichnikova TIa; Gasparov AS
    Akush Ginekol (Mosk); 1989 Apr; (4):3-6. PubMed ID: 2665539
    [No Abstract]   [Full Text] [Related]  

  • 23. [Estrogen production in adolescent girls with primary sclerocystic ovaries].
    Kulikova LF; Levenets SA; Tuchkina IA; Cherevatova SKh
    Akush Ginekol (Mosk); 1988 Mar; (3):25-7. PubMed ID: 3400824
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sclerocystic ovary syndrome].
    Vikhliaeva EM
    Akush Ginekol (Mosk); 1973 Mar; 49(3):54-8. PubMed ID: 4760972
    [No Abstract]   [Full Text] [Related]  

  • 25. [Polycystic ovaries].
    Laatikainen T
    Duodecim; 1985; 101(15):1447-53. PubMed ID: 4042899
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of the clomiphene test for evaluation of the functional state of the hypothalamus-pituitary gland-ovarian system in ovarian hyperandrogenia].
    Zelenetskaia VS; Dobracheva AD; Pishchulin AA; Zheldak LV; Razmadze TG
    Probl Endokrinol (Mosk); 1978; 24(4):36-41. PubMed ID: 683967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sclerocystic ovary syndrome].
    Kiriushchenkov AP
    Feldsher Akush; 1980; 45(12):56-8. PubMed ID: 6906297
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypothalamic-pituitary dysfunction in polycystic ovarian disease.
    Adashi EY
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):649-66. PubMed ID: 3143565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reproductive function following the surgical treatment of polycystic ovary syndrome].
    Kachalina TS; Dobrotina AF
    Akush Ginekol (Mosk); 1988 May; (5):62-3. PubMed ID: 3177780
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary amenorrhoea. A study based on clinical examination, chromosomal analysis, endocrine assay and laparoscopy.
    Khoo SK; Mackay EV
    Med J Aust; 1972 Oct; 2(18):991-6. PubMed ID: 4269129
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse.
    Couse JF; Bunch DO; Lindzey J; Schomberg DW; Korach KS
    Endocrinology; 1999 Dec; 140(12):5855-65. PubMed ID: 10579351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Pituitary-ovarian relationships in polycystic ovarian disease.
    Baird DT; Corker CS; Fraser WM; Michie EA; Van Look PF
    J Endocrinol; 1975 Mar; 64(3):53P-54P. PubMed ID: 1133543
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gonadotropic function of the pituitary gland in women in the acute period of craniocerebral injury].
    Rotkina IE
    Probl Endokrinol Gormonoter; 1966; 12(4):41-5. PubMed ID: 6002012
    [No Abstract]   [Full Text] [Related]  

  • 34. [Polycystic ovary: old concepts, new perspectives].
    Herrera Pombo JL
    Rev Clin Esp; 1989 Dec; 185(9):433-5. PubMed ID: 2696005
    [No Abstract]   [Full Text] [Related]  

  • 35. Naloxone does not interfere with the dopamine-induced decrease in gonadotropin secretion in women with polycystic ovarian disease.
    Paradisi R; Margrini O; Venturoli S; Fabbri R; Porcu E; Stanzani L; Flamigni C
    Horm Metab Res; 1985 Jan; 17(1):29-31. PubMed ID: 3917966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current methods of the treatment of patients with sclerocystic ovary syndrome].
    Pamfamirov IuK; Golubev VA; Ferzhaui AB
    Akush Ginekol (Mosk); 1989 Feb; (2):14-7. PubMed ID: 2655483
    [No Abstract]   [Full Text] [Related]  

  • 37. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
    Barnes RB; Rosenfield RL; Burstein S; Ehrmann DA
    N Engl J Med; 1989 Mar; 320(9):559-65. PubMed ID: 2521688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?
    Dunaif A
    J Clin Endocrinol Metab; 1986 Jul; 63(1):215-21. PubMed ID: 3086357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New findings in the pathogenesis of the sclerocystic ovary syndrome].
    Benediktov II; Barats SS; Shardin SA; Benediktov DI
    Akush Ginekol (Mosk); 1983 Nov; (11):43-5. PubMed ID: 6666799
    [No Abstract]   [Full Text] [Related]  

  • 40. [Endocrinological evaluation of polycystic ovary].
    Tojo S; Fukunishi H; Koui I; Osawa E
    Horumon To Rinsho; 1969 Nov; 17(11):897-904. PubMed ID: 5391109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.